24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Fitch
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:29
The economic engine of airlines is not just in the planes
15:11
Full list of Israeli high-tech funding rounds in 2026
15:07
Israeli startup raises $6.2 million to turn social media video into intelligence
15:00
Cyber unicorn Semperis acquires MightyID in $20 million identity security deal
More stories
Buzz
Most popular
Daily
Weekly
1
Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”
2
Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race
3
Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion
4
After $400M cyber exit, ex-IntSights CEO raises $11M to build AI app for personalized sports highlights
5
“SaaS is dying as a business category”
More news
Fitch
9 stories about Fitch
Intel downgraded to just above junk status with negative outlook
05.08.25
|
CTech and Reuters
Fitch cites increasing risk, rising competition, and weak financial metrics.
Has Israel become too risky for foreign capital?
18.08.24
|
Adrian Filut
Credit downgrades and rising CDS rates highlight deepening economic woes.
Fitch cuts Israel’s credit rating, citing geopolitical turmoil
13.08.24
|
Reuters
Gaza conflict and rising regional tensions drive negative outlook.
Fitch reaffirms Israel's A+ rating, removes Negative Watch
02.04.24
|
Reuters
Fitch ratings' outlook for Israel remains negative to "reflect the combination of uncertainties around the fiscal trajectory and the war's duration and intensity, including the risk of regional escalation."
Fitch Affirms Israel’s A+ Rating, Citing Strong Growth
01.09.19
|
Omri Milman
The credit rating agency affirmed the rating with a stable outlook, estimating the deficit will grow to 3.6% of GDP in 2019, in line with the forecasts of the Israeli Ministry of Finance
Fitch Downgrades Teva, Keeps Outlook at Negative
10.06.19
|
Hezi Sternlicht
Fitch pins the downgrade on the drugmaker's slow revenue growth, persisting cost challenges and downward pressure on generic drug prices, and the company's legal trouble in the U.S.
High Government Debt Countered by Strong Finances Leads Fitch to Affirm Israel's A+ Rating
26.03.19
|
Lilach Baumer
Israel scores above the median on GDP growth and human development indicators, but low on government budget deficit, government debt, and ease of doing business
JPMorgan Downgrades Teva’s Stock to Underweight
13.11.17
|
Amarelle Wenkert
Christopher Schott, managing director at JPMorgan, said that the decision to downgrade is based on the challenges facing Teva’s generic drug unit
Fitch Downgrades Teva to Junk Rating
07.11.17
|
Yaniv Rahimi
The U.S. credit agency changed Teva's rating from BBB to BB, with a negative outlook, due to "significant operational stress." The downgrade might affect Teva's ability to take on additional debt